Breaking: Tobacco nicotine destroys nanobots in shots

A new study by microscopists with La Quinta Columna has shown that the “self assembling entities” found inside Pfizer, Moderna, and most recently, dental anesthetic, are “totally destroyed” by a nicotine mixture, derived from stepping tobacco in distilled water.

Researcher Rafa Calvin made this discovery by isolating a sample of dental anesthetic for 30 days, then applying a nicotine mixture taken from a solution of 1 gram of Tabacco and 5ccs of distilled water.

In the video below, you can see that when the nicotine mixture interacts with the nanotechnology, the structures disintegrate and disappear completely.

La Quinta Columna is now testing this nicotine solution on a Pfizer shot sample, and if successful, may have the beginnings of a treatment protocol for detoxing humans of this alien technology.

This would include use of nicotine without additives, straight from tobacco, not cigarettes you buy in the store.

Nicotine has already been identified by Dr. Bryan Ardis and others to uniquely combat covid infection, by safeguarding receptors, a phenomenon even recognized by establishment scientists.

Could nicotine hold the key to defeating invasive nanotechnology?

Nicotine, a potent alkaloid found primarily in tobacco plants, is being explored for its potential impact on nanotechnology-based vaccinations. As a well-known stimulant, nicotine operates by mimicking neurotransmitters in the brain, leading to increased alertness and concentration.

Research into nicotine’s effect on nanotechnology in vaccinations is in its early conceptual stages. Some studies suggest that nicotine’s molecular structure could influence the stability and delivery mechanisms of nanoparticle-based vaccines. This could potentially enhance the efficacy of vaccines by ensuring more precise targeting and prolonged presence in the body.

Moreover, nicotine is being investigated for its role in modulating the immune system. While traditionally seen as an immune suppressant, emerging research is probing whether its immune response modulation could be beneficial in optimizing vaccine design and delivery.

However, nicotine’s addictive properties and health risks, particularly related to cardiovascular health, present significant challenges. These concerns necessitate careful consideration regarding dosage and delivery methods in any potential applications.

In the realm of inflammation, nicotine might play a part in influencing inflammatory pathways at the nanoscale level. This property is under examination for its possible utility in reducing vaccine-related inflammation and enhancing patient comfort and compliance.

The exploration of nicotine’s role in cancer treatment, notably through its interaction with nanoparticle drug carriers, is also gathering attention. Here, nicotine’s ability to interact with specific cellular receptors is being assessed for its potential to increase the specificity and efficacy of cancer vaccines.

Extensive research, including human clinical trials, is however still required to understand fully nicotine's effects on nanotechnology in vaccinations and to determine safe application strategies that encompass its benefits without the risks.